학술논문

A phase 1, first-in-human, open-label, dose escalation and dose expansion study of TST005 in patients with locally advanced or metastatic solid tumors.
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2531-2531, 1p
Subject
Language
ISSN
0732183X